Yahoo Web Search

Search results

1. • 

     Clubhouse programs take pressure off overwhelmed Texas mental health hospitals

     Associated Press· 47 minutes ago

     When Jonathan Denhart was discharged from the psych ward at Austin Oaks Hospital last year, he was...

2. • Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology

     Digital Journal· 3 hours ago

     North of Soledar, Ukrainians yearn for peace Carlo Marks talks about his new Hallmark movie ‘The Wedding Veil Inspiration’ Musk faces US fraud trial over Tesla tweet Heat ...

3. • ...Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine...

     Benzinga· 2 days ago

     TNG, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer today announces that the first patient has been enrolled in the Phase II part of the ...

4. • SPHHP dean contributes to JAMA paper on WHI

     UB Reporter· 10 hours ago

     The JAMA paper was intended to assist clinicians in interpreting the trial findings according to type of medication and personal factors that might help with understanding ...

5. • ... Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in...

     WLNS Lansing· 4 days ago

     Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term follow-up results, including the first-ever overall survival (OS) findings, from the Phase 2b HERIZON-BTC-01 clinical ...

6. • Arbutus' Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity...

     Benzinga· 10 hours ago

     At the end of treatment, 33.3% of patients receiving imdusiran for 48 weeks, interferon (IFN) for 24 weeks and ongoing nucleoside analogue (NA) therapy achieved undetectable levels of HBsAg that were maintained in 100%

7. • 

     UCLA oncologist Dr. Dennis Slamon awarded Szent-Gy | Newswise

     Newswise· 12 hours ago

     Dr. Dennis Slamon, a world-renowned oncologist and scientist whose groundbreaking research has...

8. • 

     Kardium reports positive Globe system trial results for AF treatment

     Medical Device Network via Yahoo Finance· 6 days ago

     PULSE-EU reported no major adverse events related to the device...Chaplin said: “These excellent...

9. • Promising Phase 2 Results For Biodexa's eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have...

     Morningstar· 2 days ago

     In a clinical trial involving 30 adult patients, three groups received the same dose of the drug but with different regimens over a period of 12 months.

10. • 

      Pfizer drug extends life for people with rare form of lung cancer

      AFP via Yahoo News· 5 days ago

      A Pfizer lung cancer drug has been shown to greatly reduce tumor progression and improve survival...